Navitas Life Sciences

Can Pharmacovigilance meet the COVID-19 Challenge?

A checklist approach to PV Business Continuity 

In this new world, driven by COVID-19, there is pressure on pharma companies to accelerate their drug development while, at the same time, maintaining integrity of their PV operations. The level of vigilance for patient safety must not be compromised.

Please complete the form to download our paper – Can Pharmacovigilance meet the COVID-19 challenge? 


Please complete form to download the pdf
First Name
✽
Last Name
✽
Business Email
✽
Company
✽
Job Title
✽
Country
✽
By submitting this form, I agree to receive email communications from Navitas Life Sciences. Privacy Policy

© 2020 Navitas Life Sciences | Privacy Policy